Virtual BC COVID-19 Symposium
Introduction and Overview
Bonnie Henry, Provincial Health Officer
David Patrick, BCCDC; UBC
Robert McMaster, UBC
Diagnostics, Genomics and Transmission Dynamics
Natalie Prystajecky
Mel Krajden, BCCDC
Steve Jones, GSC
Peter Unrau, SFU
Clinical Trials and Patient Management
Josef Penninger, UBC
Srin Murthy, UBC
Jim Russell, UBC
Richard Lester, UBC
Epidemiology & Public Health Response
Danuta Skowronski, BCCDC
Manish Sadarangani, BCCH
Caroline Colijn SFU & Michael Otterstatter
Social Dynamics, Communications and Trust
Cynthia Jardine, University of The Fraser Valley
Yue Qian, UBC
Kelley Lee & Julia Smith, SFU
Emily Rempel, CDC
Development of Therapeutics and Vaccines
Bo Barnhart, AbCellera, Inc
Artem Cherkasov, UBC
Eric Jan, UBC
Francois Jean, UBC
Horacio Bach, UBC
Sriram Subramaniam, UBC
Wilf Jefferies, UBC
Leonard Foster, UBC
James Taylor, Precision NanoSystems
Lindsay Eltis, UBC
Final Discussions and Summary
下面是上禮拜聽的時候截圖的筆記
BC testing capacity. Genome BC is involved, too.
BC's sequencing equipment
BC COVID-19 WGS (whole Genome Sequencing) - mostly from Washington state and Europe
WHO's SOLIDARITY projects: clinical trials of the 4 focused treatments
Canada also participates: Canadian Arm of SOLIDARITY (CATCO)
Science / WHO launches global megatrial of the four most promising coronavirus treatments (March 2020)
ARBs (angiotensin II type 1 receptor blockers)
clinical trial: Coronavirus ACEi/ARB Investigation (CORONACION)
Causes of ACI and how SARS-CoV-2 is related to it.
UBC's APN01 works against ACE2
可參考：UBC 研發的藥物將進入臨床試驗 -- soluble hrsACE2
BC 和全加拿大的新冠病毒患者的年齡分佈
tracking COVID-19 by sero-prevalence survey
之前看到 UCSF 在做血清檢測，想說 BC 應該也要做一下，原來真的有計畫要做。
Science / Unprecedented nationwide blood studies seek to track U.S. coronavirus spread (April 2020)
患者體內免疫反應的研究，確診患者如果還在症狀出現後的十四天內，想為疫苗研發貢獻一份心力的，可和研究團隊聯絡，e-mail 如上。
相關文章：武漢肺炎輕症患者體內的免疫反應
BC 目前和計畫中的相關研究
Transmission & control modelling for decision making and public health response
BC 目前是最右邊那個
AbCellera antibody discovery - they use single cell sequencing
他們有和美國 NIH 和 Eli Lilly 合作。
AbCellera news press: AbCellera and Lilly to Co-develop Antibody Therapies for the Treatment of COVID-19
沒有留言:
張貼留言
歡迎發表意見